» Articles » PMID: 11261879

The Use of Immunoliposomes for Specific Delivery of Antimicrobial Agents to Oral Bacteria Immobilized on Polystyrene

Overview
Date 2001 Mar 23
PMID 11261879
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Antibacterial immunoliposomes have been prepared using covalently bound antibody, raised to the cell surface of the bacterium Streptococcus oralis (S. oralis), and incorporating the bactericides chlorhexidine and Triclosan. A regrowth assay, in which the ability of a bacterial biofilm immobilised on polystyrene to grow after exposure to a test solution, was undertaken to study the action of the antibacterial immunoliposomes. The antibacterial anti-oralis immunoliposomes show enhanced growth inhibition of S. oralis, compared to free bactericide, using low bactericide concentrations. For short exposure times to the biofilms, antibacterial anti-oralis immunoliposomes can show several times enhanced growth inhibition of S. oralis compared to free bactericide. Antibacterial anti-oralis immunoliposomes inhibit the growth of S. oralis more than that of other oral bacteria. The extent of growth inhibition by antibacterial anti-oralis immunoliposomes is linearly related to the number of immunoliposomes targeted to the biofilm surface.

Citing Articles

Liposomes-Based Drug Delivery Systems of Anti-Biofilm Agents to Combat Bacterial Biofilm Formation.

Makhlouf Z, Ali A, Al-Sayah M Antibiotics (Basel). 2023; 12(5).

PMID: 37237778 PMC: 10215698. DOI: 10.3390/antibiotics12050875.


Current status and future of delivery systems for prevention and treatment of infections in the oral cavity.

Senel S, Ozdogan A, Akca G Drug Deliv Transl Res. 2021; 11(4):1703-1734.

PMID: 33770415 PMC: 7995675. DOI: 10.1007/s13346-021-00961-2.


Enhanced eradication of intracellular and biofilm-residing methicillin-resistant Staphylococcus aureus (MRSA) reservoirs with hybrid nanoparticles delivering rifampicin.

Guo P, Xue H, Buttaro B, Tran N, Wong H Int J Pharm. 2020; 589:119784.

PMID: 32877731 PMC: 7854488. DOI: 10.1016/j.ijpharm.2020.119784.


Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilms.

Guo P, Buttaro B, Xue H, Tran N, Wong H Eur J Pharm Biopharm. 2020; 151:189-198.

PMID: 32335285 PMC: 7266653. DOI: 10.1016/j.ejpb.2020.04.010.


Lipid-Based Antimicrobial Delivery-Systems for the Treatment of Bacterial Infections.

Wang D, van der Mei H, Ren Y, Busscher H, Shi L Front Chem. 2020; 7:872.

PMID: 31998680 PMC: 6965326. DOI: 10.3389/fchem.2019.00872.